D.E. Shaw & Co
MURA

D.E. Shaw & Co’s Mural Oncology MURA Stock Holding History

D.E. Shaw & Co’s Portfolio MURA Stock Details MURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-28,427
Closed -$168K – 4596
2023
Q4 		$168K Buy
+28,427
New +$114K ﹤0.01% 3910

Other funds holding MURA

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Verition Fund Management
Verition Fund Management Greenwich, Connecticut $15.4B AUM 30.69% 1-Year Est. Return
SCM
Solas Capital Management Darien, Connecticut $174M AUM 6.33% 1-Year Est. Return
AFA
Alta Fundamental Advisers New York $265M AUM 98.61% 1-Year Est. Return
NM
Newtyn Management New York $936M AUM 27.23% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

D.E. Shaw & Co's MURA Position: Q1 2024 in Review

D.E. Shaw & Co sold out of Mural Oncology (MURA) in Q1 2024, closing a stake of 28,427 shares — an estimated $168K sold.

D.E. Shaw & Co first reported a position in MURA in Q4 2023 and held it in 1 quarter. The position peaked at $168K in Q4 2023. 101 funds tracked by Wall St. Rank hold MURA as of Q1 2024.

  • D.E. Shaw & Co reported no remaining Mural Oncology position as of Q1 2024 after selling out during the quarter.
  • D.E. Shaw & Co sold 28,427 Mural Oncology shares in Q1 2024, an estimated $168K.
  • D.E. Shaw & Co first reported a position in Mural Oncology in Q4 2023 and held it in 1 quarter.
  • D.E. Shaw & Co's Mural Oncology position peaked at $168K in Q4 2023.
  • 101 funds tracked by Wall St. Rank held Mural Oncology as of Q1 2024.

Based on D.E. Shaw & Co's 13F filing for Q1 2024, filed 15 May 2024.